Hearing Loss and Tinnitus Are Common In Cancer Survivors

While children receiving chemotherapy routinely undergo hearing tests, adults don’t, and a new study by UC San Francisco reports for the first time that significant hearing issues often occur among adult survivors of the most common forms of cancer. The researchers found that more than half the

An atlas of oesophageal cancer development

From the team taking on our Cancer Causes challenge, a new integrated atlas of the stromal and epithelial interactions that drive cancers associated with chronic inflammation provides a new way to understand cancer types with the poorest survival. Inflammation – the immune system’s normal response

Scientists Map Networks of Disease-Associated Immune Genes

Using new technologies to study thousands of genes simultaneously within immune cells, researchers at Gladstone Institutes, UC San Francisco (UCSF), and Stanford School of Medicine have created the most detailed map yet of how complex networks of genes function together. The new insights into how

World-Renowned Expert Joins UCSF as Hematology and Oncology Division Chief

Krishna Komanduri, MD, an international leader in hematology-oncology, transplantation and cellular immunotherapy, is the new chief of UCSF’s Division of Hematology and Oncology. He is also physician-in-chief of the UCSF Helen Diller Family Comprehensive Cancer Center and clinical director of the

Training the Eye to See Disease On Dark Skin

Jonas wears the close-shaved natural hairstyle that’s on-trend for many Black men. He’s been styling his hair this way for years, but during the pandemic he noticed, a few days after each shave, some spots on his scalp that hurt or even bled a little. When the pain and bleeding started to spread, he

Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today's Visionaries in Cancer Immunotherapy Research

The Cancer Research Institute (CRI), a nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all types of cancer, announced today the newest cohort of scientists chosen for the CRI Lloyd J. Old STAR Program (Scientists Taking Risks). Each STAR will receive

2022 Precision Medicine World Conference Back In Person, Features Extensive UCSF Presence

For the seventh consecutive year, UC San Francisco is co-sponsoring the Precision Medicine World Conference (PMWC) on June 28-30, 2022, to share the latest in this rapidly evolving space. The conference will be held in person after being virtual for the past two years due to the pandemic and will